FNY Investment Advisers’s AngioDynamics ANGO Stock Holding History

FNY Investment Advisers’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-349	Closed	-$7K	–	888
2018 Q2	$7K	Buy	+349	New	+$7.13K	﹤0.01%	519

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

FNY Investment Advisers's ANGO Position: Q3 2018 in Review

FNY Investment Advisers sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 349 shares — an estimated $7K sold.

FNY Investment Advisers first reported a position in ANGO in Q2 2018 and held it in 1 quarter. The position peaked at $7K in Q2 2018. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

FNY Investment Advisers reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
FNY Investment Advisers sold 349 AngioDynamics shares in Q3 2018, an estimated $7K.
FNY Investment Advisers first reported a position in AngioDynamics in Q2 2018 and held it in 1 quarter.
FNY Investment Advisers's AngioDynamics position peaked at $7K in Q2 2018.
177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on FNY Investment Advisers's 13F filing for Q3 2018, filed 29 Oct 2018.